$1.23Billion | No. of Holdings #22
Novo Holdings A/S Performance
| Ticker | $ Bought |
|---|---|
| xenon pharmaceuticals inc | 28,228,200 |
| Ticker | % Inc. |
|---|---|
| salesforce inc | 19.08 |
| bridgebio oncology therapeut | 11.45 |
| mirum pharmaceuticals inc | 4.82 |
| Ticker | % Reduced |
|---|---|
| valneva se | -54.12 |
| apogee therapeutics inc | -21.05 |
| asml holding n v | -16.67 |
| viridian therapeutics inc | -15.97 |
| enliven therapeutics inc | -13.51 |
| vaxcyte inc | -6.13 |
| crinetics pharmaceuticals in | -4.62 |
| Ticker | $ Sold |
|---|---|
| io biotech inc | -1,529,830 |
| zenas biopharma inc | -52,649,500 |
| insmed inc | -34,808,000 |
NOVO HOLDINGS A/S has about 47.4% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 47.4 |
| Healthcare | 46.5 |
| Technology | 6.1 |
NOVO HOLDINGS A/S has about 9% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 47.4 |
| MID-CAP | 37.6 |
| LARGE-CAP | 9 |
| SMALL-CAP | 6 |
About 47.2% of the stocks held by NOVO HOLDINGS A/S either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 52.7 |
| RUSSELL 2000 | 41.3 |
| S&P 500 | 5.9 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
NOVO HOLDINGS A/S has 22 stocks in it's portfolio. About 73.9% of the portfolio is in top 10 stocks. CRM proved to be the most loss making stock for the portfolio. EWTX was the most profitable stock for NOVO HOLDINGS A/S last quarter.
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
ASML Asml Holding N VAsml Holding N VASML | 10.16% | 94,946 | $125.41M 10.16% | 16.67%decreased 16.67 percentreduced | |
BABA Alibaba Group Hldg LtdAlibaba Group Hldg LtdBABA | 2.62% | 257,327 | $32.28M 2.62% | 0%unchanged 0 percentunchanged | |
Biomarin Pharmaceutical Inc Novo Holdings A/S's holding in Biomarin Pharmaceutical Inc over time | 3.02% | 660,000 | $37.28M 3.02% | 0%unchanged 0 percentunchanged | |
Celldex Therapeutics Inc New Novo Holdings A/S's holding in Celldex Therapeutics Inc New over time | 3.08% | 1,200,000 | $38.06M 3.08% | 0%unchanged 0 percentunchanged | |
Salesforce Inc Novo Holdings A/S's holding in Salesforce Inc over time | 5.95% | 393,187 | $73.40M 5.95% | 19.08%increased 19.08 percentadded | |
Crinetics Pharmaceuticals In Novo Holdings A/S's holding in Crinetics Pharmaceuticals In over time | 4.56% | 1,550,000 | $56.30M 4.56% | 4.62%decreased 4.62 percentreduced | |
Edgewise Therapeutics Inc Novo Holdings A/S's holding in Edgewise Therapeutics Inc over time | 13.65% | 5,350,000 | $168.53M 13.65% | 0%unchanged 0 percentunchanged | |
4d Molecular Therapeutics In Novo Holdings A/S's holding in 4d Molecular Therapeutics In over time | 2.75% | 3,650,740 | $33.99M 2.75% | 0%unchanged 0 percentunchanged | |
Insmed Inc Insmed IncINSM Novo Holdings A/S's holding in Insmed Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Io Biotech Inc Io Biotech IncIOBT Novo Holdings A/S's holding in Io Biotech Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Mirum Pharmaceuticals Inc Novo Holdings A/S's holding in Mirum Pharmaceuticals Inc over time | 9.92% | 1,325,000 | $122.40M 9.92% | 4.82%increased 4.82 percentadded | |
Marqeta Inc Novo Holdings A/S's holding in Marqeta Inc over time | 0.15% | 441,558 | $1.80M 0.15% | 0%unchanged 0 percentunchanged | |
Vaxcyte Inc Vaxcyte IncPCVX Novo Holdings A/S's holding in Vaxcyte Inc over time | 4.05% | 860,000 | $49.97M 4.05% | 6.13%decreased 6.13 percentreduced | |
PHVS Pharvaris N VPharvaris N VPHVS | 4.01% | 1,750,000 | $49.44M 4.01% | 0%unchanged 0 percentunchanged | |
VALN Valneva SeValneva SeVALN | 0.54% | 1,057,420 | $6.61M 0.54% | 54.12%decreased 54.12 percentreduced | |
Viridian Therapeutics Inc Novo Holdings A/S's holding in Viridian Therapeutics Inc over time | 3.17% | 2,000,000 | $39.12M 3.17% | 15.97%decreased 15.97 percentreduced | |
Xenon Pharmaceuticals Inc Novo Holdings A/S's holding in Xenon Pharmaceuticals Inc over time | 2.29% | 485,438 | $28.23M 2.29% | Newnew position | |
Cl A Ltd Vt Sh Brookfield CorpBrookfield Corp | 11.46% | 3,496,240 | $141.49M 11.46% | 0%unchanged 0 percentunchanged | |
Com Maplight Therapeutics IncMaplight Therapeutics Inc | 6.07% | 3,686,620 | $74.95M 6.07% | 0%unchanged 0 percentunchanged | |
Com Enliven Therapeutics IncEnliven Therapeutics Inc | 4.07% | 1,280,000 | $50.18M 4.07% | 13.51%decreased 13.51 percentreduced | |